Arbutus Biopharma Corp. (ABUS)
5.14
+0.05
(+0.98%)
USD |
NASDAQ |
Sep 02, 10:40
Arbutus Biopharma Net Income (TTM) : 153.05M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 153.05M |
| March 31, 2026 | 160.72M |
| December 31, 2025 | -33.50M |
| September 30, 2025 | -42.28M |
| June 30, 2025 | -54.25M |
| March 31, 2025 | -76.57M |
| December 31, 2024 | -69.92M |
| September 30, 2024 | -76.70M |
| June 30, 2024 | -77.09M |
| March 31, 2024 | -74.38M |
| December 31, 2023 | -72.85M |
| September 30, 2023 | -75.47M |
| June 30, 2023 | -72.93M |
| March 31, 2023 | -70.03M |
| December 31, 2022 | -69.46M |
| September 30, 2022 | -68.84M |
| June 30, 2022 | -70.44M |
| March 31, 2022 | -75.63M |
| December 31, 2021 | -76.25M |
| September 30, 2021 | -71.97M |
| June 30, 2021 | -71.56M |
| March 31, 2021 | -66.26M |
| December 31, 2020 | -63.74M |
| September 30, 2020 | -71.36M |
| June 30, 2020 | -135.10M |
| Date | Value |
|---|---|
| March 31, 2020 | -144.33M |
| December 31, 2019 | -153.72M |
| September 30, 2019 | -147.32M |
| June 30, 2019 | -89.29M |
| March 31, 2019 | -62.88M |
| December 31, 2018 | -57.06M |
| September 30, 2018 | -74.74M |
| June 30, 2018 | -61.87M |
| March 31, 2018 | -83.22M |
| December 31, 2017 | -84.41M |
| September 30, 2017 | -267.18M |
| June 30, 2017 | -275.17M |
| March 31, 2017 | -386.92M |
| December 31, 2016 | -384.16M |
| September 30, 2016 | -170.73M |
| June 30, 2016 | -180.12M |
| March 31, 2016 | -65.01M |
| December 31, 2015 | -61.12M |
| September 30, 2015 | -62.02M |
| June 30, 2015 | -41.65M |
| March 31, 2015 | -32.84M |
| December 31, 2014 | -38.84M |
| September 30, 2014 | -35.27M |
| June 30, 2014 | -32.52M |
| March 31, 2014 | -29.47M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Moderna, Inc. | -3.151B |
| Insmed, Inc. | -875.31M |
| Pfizer Inc. | 4.373B |
| Gossamer Bio, Inc. | -125.22M |
| Legend Biotech Corp. | -91.90M |